Matthew H. Kulke, MD, medical oncologist and hematologist, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, May 27 from 12 noon to 1 pm, Eastern Time. Dr. Kulke is the Chief of Hematology/Oncology, Co-Director of the BU/BMC Cancer Center and Zoltan Kohn Professor at the Boston University School of Medicine.
Recognized internationally for his work in the field of neuroendocrine tumors (NETs), Dr. Kulke has led or co-led both early and late stage clinical trials leading to the development of telotristat ethyl, temozolomide, sunitinib, everolimus and peptide receptor radionuclide therapy (PRRT) for the treatment of NETs. His work has additionally included characterization of neuroendocrine tumors at the molecular level, and has resulted in over 200 peer-reviewed publications.
Prior to coming to Boston University he was a Professor of Medicine at Harvard Medical School and Director of the Neuroendocrine Tumor Program at Dana-Farber Cancer Institute in Boston, Massachusetts. He has served as principal investigator for NCI cooperative group trials in both neuroendocrine tumors and pancreatic cancer, served as chair of the National Cancer Institute’s Neuroendocrine Tumor Clinical Trial Task Force, chair of the North American Neuroendocrine Tumor Society, and chair of the National Comprehensive Cancer Network’s neuroendocrine tumor guidelines committee.
In 2020, Dr. Kulke was honored by NANETS, the North American Neuroendocrine Tumor Society, with the medical organization’s Lifetime Achievement Award. This award recognizes and honors a medical professional who has made a lasting and worthwhile contribution to the field of neuroendocrine tumors, and who has served NANETS in its efforts to improve the outcomes for patients with NETs through multidisciplinary medical education, NET-related medical research, publication of guidelines and the exchange of knowledge and innovation.
CCF’s Luncheon with the Experts series features physicians and healthcare professionals, support group leaders, patients, and colleagues who are key opinion leaders in the neuroendocrine cancer community worldwide. This weekly series is presented via Facebook Live on Thursdays from 12 noon to 1 pm, Eastern Time. Join us for unique discussions on a wide variety of topics for everyone in the NET community!
To view the program come to CCF’s Facebook page, https://www.facebook.com/Carcinoid/, at noon Eastern Time. There is no need to register and there is no special link.
Viewers are welcome to pose questions during the live program.
The Facebook Live events are hosted by B. Rain Bennett, a longtime CCF filmmaker and dear friend of the NETs community.
If you are on Facebook but unable to join at the scheduled time, the presentations will remain permanently on CCF’s Facebook page in the Video section, https://www.facebook.com/pg/Carcinoid/videos/. You can view all of the 2020-2021 presentations at that link too.
And for anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK LIKE, SUBSCRIBE, and HIT THE BELL to receive notifications each time a new video is uploaded.
With special thanks to TerSera Therapeutics, sponsor of the Luncheon with the Experts series.
Sign up for our e-newsletter to receive notifications about all upcoming Luncheon with the Experts programs, every Thursday from noon to 1 pm ET, as well as lots of additional news of interest to the NET community: https://bit.ly/SignUpCCFe-news